4//SEC Filing
EYETECH PHARMACEUTICALS INC 4
Accession 0001293941-05-000058
CIK 0001115285operating
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 5:08 PM ET
Size
6.3 KB
Accession
0001293941-05-000058
Insider Transaction Report
Form 4
GUYER DAVID R
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2005-08-01$11.33/sh−15,600$176,748→ 1,178,239 total
Holdings
- 30,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 Plan dated April 25, 2005.
- [F2]These shares are held in a trust for the benefit of the reporting person's children. The reporting person's mother is trustee of the Trust. The reporting person disclaims beneficial ownership of these securites and the filing of this report is not an admission that the reporting person is a beneficial owner of these securities for Section 16 or any other purpose.
Documents
Issuer
EYETECH PHARMACEUTICALS INC
CIK 0001115285
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001115285
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 5:08 PM ET
- Size
- 6.3 KB